New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 30, 2014
07:46 EDTNBSNeoStem subsidiary enters into services agreement with IRX Therapeutics
NeoStem and its subsidiary, Progenitor Cell Therapy, announced the execution of a Services Agreement with IRX Therapeutics, under which PCT will provide services to support IRX's development of IRX-2, a primary cell-derived biologic with multiple active cytokine components. IRX-2 is a cancer therapeutic designed to activate a patient's immune system to broadly restore immunity and overcome cancer-induced immune suppression. IRX has engaged PCT for the manufacture of an intermediate component referred to as IRX-2 Drug Substance for human clinical trials.
News For NBS From The Last 14 Days
Check below for free stories on NBS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 11, 2014
07:32 EDTNBSNeoStem licenses patent portfolio from Rockefeller University
Subscribe for More Information
September 8, 2014
07:18 EDTNBSRodman & Renshaw to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use